Advertisement
Device Sectors
Subscribe to Device Sectors
View Sample

FREE Email Newsletter

Neurocrine Biosciences To Present at the Stifel Nicolaus 2011 Healthcare Conference

September 1, 2011 9:36 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, Sept. 1, 2011 /- Neurocrine Biosciences, Inc. (Nasdaq: NBIX ) announced today that Kevin Gorman, President and Chief Executive Officer of Neurocrine Biosciences, will be presenting at the Stifel Nicolaus 2011 Healthcare Conference in Boston.   The live presentation...

Floridians Recognized for Role in Helping Rare Disease Patients Who Need Lifesaving Therapies

September 1, 2011 9:34 am | by Bio-Medicine.Org | News | Comments

ANNAPOLIS, Md., Sept. 1, 2011 /- This month, Floridians are recognizing "Plasma Protein Therapies Month," by raising awareness for the valuable contributions of plasma donors throughout the "Sunshine State" and for the rare, genetic diseases treated with the therapies that are made...

Californians Recognized For Role In Helping Rare Disease Patients Who Need Lifesaving Therapies

September 1, 2011 9:33 am | by Bio-Medicine.Org | News | Comments

ANNAPOLIS, Md., Sept. 1, 2011 /- This month, Californians are recognizing "Plasma Protein Therapies Month," by raising awareness for the valuable contributions of plasma donors throughout the "Golden State" and for the rare, genetic diseases treated with the therapies that are made...

Advertisement

Californians and Floridians Recognized for Role in Helping Rare Disease Patients Who Need Lifesaving Therapies

September 1, 2011 6:34 am | by Bio-Medicine.Org | News | Comments

ANNAPOLIS, Md., Sept. 1, 2011 /- This month, Florida and California are recognizing "Plasma Protein Therapies Month," by raising awareness for the valuable contributions of plasma donors and for the rare, genetic diseases treated with the therapies that are made possible through plasma...

diaDexus to Present at the RW Baird 2011 Health Care Conference

September 1, 2011 6:34 am | by Bio-Medicine.Org | News | Comments

SOUTH SAN FRANCISCO, Calif., Sept. 1, 2011 /- diaDexus, Inc. (OTC Bulletin Board: DDXS.OB), a diagnostics company focused on the development and commercialization of patent-protected in vitro diagnostic products addressing unmet needs in cardiovascular disease, today said that it plans...

New Polar Move Heart Rate Monitor for Students Facilitates Effective and Safe Physical Education

September 1, 2011 6:34 am | by Bio-Medicine.Org | News | Comments

LAKE SUCCESS, N.Y., Sept. 1, 2011 /- Polar ( www.polarusa.com ), the leader in heart rate monitoring and fitness assessment technologies, today introduced the Polar Move . The new heart rate monitor is designed specifically around the needs of the education market. Its introduction...

Leading Expert's Heart Health Advice: Flush Your "Flush-Free" Dietary Supplement Niacin

September 1, 2011 4:34 am | by Bio-Medicine.Org | News | Comments

MAPLE GROVE, Minn., Sept. 1, 2011 /- People seeking support for healthy good cholesterol from a "flush-free" niacin supplement, prepare to be disappointed – and to make a return trip to your local pharmacy. According to leading cardiologist, Dr. Carl Lavie, medical director of...

Isis Pharmaceuticals to Present at the Stifel Nicolaus Healthcare Conference 2011

September 1, 2011 4:33 am | by Bio-Medicine.Org | News | Comments

CARLSBAD, Calif., Sept. 1, 2011 /- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS ), the leader in antisense therapeutics, today announced that management will present a company overview at Stifel Nicolaus' Healthcare Conference 2011 on Thursday, September 08, 2011 at 2:05 p.m. ET at the Four...

Advertisement

Volcano Corporation Announces Presentations at Upcoming Investor Conferences

September 1, 2011 4:33 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, Sept. 1, 2011 /- Volcano Corporation (NASDAQ: VOLC ), a leading developer and manufacturer of precision intravascular diagnosis and therapy guidance tools designed to enhance the treatment of coronary and peripheral vascular disease, said today that it will be participating...

Concord Medical Services Announces the Appointment of Mr. Adam Sun as Acting Chief Financial Officer

September 1, 2011 12:39 am | by Bio-Medicine.Org | News | Comments

BEIJING, Aug. 31, 2011 /PRNewswire-Asia-FirstCall/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company", NYSE: CCM ), the operator of the largest network of radiotherapy and diagnostic imaging centers in China, today announced that the Company has appointed...

Novo Nordisk Partners with Minneapolis Community Groups to Support Diabetes Education Programs

September 1, 2011 12:39 am | by Bio-Medicine.Org | News | Comments

MINNEAPOLIS, Aug. 31, 2011 /- This evening, Novo Nordisk awarded sponsorships totaling $100,000 to 4 Minneapolis-based community organizations to support programs that educate people living with type 2 diabetes on how to better manage their diabetes and reduce the risk of long-term...

Auxilium Pharmaceuticals, Inc. and BioSpecifics Technologies Corp. Announce Plans to Develop Additional Indications using XIAFLEX®

September 1, 2011 12:39 am | by Bio-Medicine.Org | News | Comments

MALVERN, Pa. and LYNBROOK, N.Y., Aug. 31, 2011 /- Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL ), a specialty biopharmaceutical company, and BioSpecifics Technologies Corp. (NASDAQ: BSTC ), a biopharmaceutical company, today announced that they have dismissed all pending litigation...

Vanda Pharmaceuticals to Participate in Stifel Nicolaus Global Healthcare Conference and Jefferies Fall 2011 Mid-Atlantic Corporate Access Day

September 1, 2011 12:39 am | by Bio-Medicine.Org | News | Comments

ROCKVILLE, Md., Aug. 31, 2011 /- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA ), a biopharmaceutical company focused on the development and commercialization of products for central nervous system disorders, today announced that Mihael H. Polymeropoulos, M.D., Vanda President and...

Advertisement

Hatchtech Completes Treatment Phase of 2b Clinical Trial of New-Generation Head Lice Treatment Deovoâ„¢

September 1, 2011 12:39 am | by Bio-Medicine.Org | News | Comments

MELBOURNE, Australia, Aug. 31, 2011 /PRNewswire-Asia/ -- Pharmaceutical company Hatchtech Pty Ltd has completed treatment of subjects for its Phase 2b clinical study to confirm the efficacy of its novel head lice treatment DeOvo™. This Phase 2b trial is evaluating the efficacy,...

ZINO Society, ZZIF Companies Announced

September 1, 2011 12:38 am | by Bio-Medicine.Org | News | Comments

SEATTLE, Aug. 31, 2011 /- ZINO Society's 6th Annual ZINO Zillionaire Investment Forum (ZZIF) , September 13, 2011, 8am-4pm at the Museum of History & Industry, Seattle. ZINO Zillionaire Investment Forum will showcase 35+ entrepreneurs from seed, early-stage and expansion...

Millstone Medical Outsourcing Hires Seasoned VP of Operations to Run Memphis Facility

August 31, 2011 12:35 pm | by Bio-Medicine.Org | News | Comments

FALL RIVER, Mass., Aug. 31, 2011 /- Millstone Medical Outsourcing announced today that the company hired Karl Neuberger as Vice President of Operations of the Memphis, TN, facility.  Mr. Neuberger, a highly experienced manufacturing executive, will have overall responsibility for...

Cantel Medical Corp. to Present at the CL King 9th Annual Best Ideas Conference

August 31, 2011 11:43 am | by Bio-Medicine.Org | News | Comments

LITTLE FALLS, N.J., Aug. 31, 2011 /- CANTEL MEDICAL CORP. (NYSE: CMN ) announced today that Andrew A. Krakauer, President & CEO, will be presenting at the CL King 9th Annual Best Ideas Conference. The formal presentation is scheduled for 11:15 AM EDT on Tuesday, September 13, 2011...

Accuray Launches New Organization for CyberKnife® and TomoTherapy® System Users

August 31, 2011 11:43 am | by Bio-Medicine.Org | News | Comments

SUNNYVALE, Calif., Aug. 31, 2011 /- Accuray Incorporated (Nasdaq: ARAY ), the premier radiation oncology company, announced today the launch of Accuray Exchange in Radiation Oncology (AERO), a global organization for CyberKnife® Robotic Radiosurgery System and...

Medical Device Manufacturing Conference Slated for October 19-20, 2011

August 31, 2011 11:43 am | by Bio-Medicine.Org | News | Comments

RAMSEY, N.J., Aug. 31, 2011 /- Medical Product Outsourcing magazine announces its fall 2011 MPO Symposium--the leading conference for medical device manufacturing. The event takes place on October 19-20, 2011, at The Conference Center at Waltham Woods in Waltham, Mass. The MPO Symposium...

Lupin Receives Final Approval to Market Generic Ultram® ER

August 31, 2011 11:41 am | by Bio-Medicine.Org | News | Comments

BALTIMORE, Aug. 31, 2011 /- Lupin Pharmaceuticals, Inc. (LPI) today announced that it has received final approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application (ANDA) for Tramadol Hydrochloride Extended-Release Tablets, 100, 200...

Small Town Company Thrives Against All Odds

August 31, 2011 11:40 am | by Bio-Medicine.Org | News | Comments

SIERRA MADRE, Calif., Aug. 31, 2011 /- In the quaint little town of Sierra Madre, one budding business just joined the ranks of companies such as Microsoft and Oracle. By helping hospitals all over the country, Wound Care Advantage has reached #316 on Inc. Magazine's "500" list of the...

Samsung Medison America Welcomes Brian Keith as Sales General Manager, USA

August 31, 2011 11:39 am | by Bio-Medicine.Org | News | Comments

CYPRESS, Calif., Aug. 31, 2011 /- Samsung Medison America appoints Brian Keith as Sales General Manager, USA to address a growing demand for its expansive line of Ultrasound platforms. Mr. Keith will be responsible for the US sales organization and its management in Samsung Medison...

BioBDx to Present at the 2011 BioPharm America Conference

August 31, 2011 11:37 am | by Bio-Medicine.Org | News | Comments

PLYMOUTH MEETING, Pa., Aug. 31, 2011 /- BioBDx announced today that the Company's Chairman and CEO Byron Hewett will present at the 2011 BioPharm America Conference taking place September 7-9.  BioBDx manufactures and markets the Quotient® System, a tool that objectively...

MIT cites new approaches with microRNA testing

August 31, 2011 11:36 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Researchers at MIT say they have engineered a new method to detect abnormal microRNA levels in the blood of cancer patients, raising the possibility of developing a simple blood test to diagnose or monitor the disease.

IRIDEX Expands ENT Laser Applications

August 31, 2011 2:36 am | by Bio-Medicine.Org | News | Comments

MOUNTAIN VIEW, Calif., Aug. 31, 2011 /- IRIDEX Corporation (Nasdaq: IRIX ) announced the introduction of its new XP Module - a high power factory installed option for the IRIDEX IQ 532 green laser system. The IQ 532 XP is a multifunctional device that can be utilized by both ear, nose...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading